First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens. |
Link to Journal |
Challenges in diagnosis of central nervous system infections using conventional method: Need for better approach in Rwanda. |
Link to Journal |
Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine |
Link to Journal |
Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa. |
Link to Journal |
Association between non-barrier modern contraceptive use and condomless sex among HIV-positive female sex workers in Mombasa, Kenya: A prospective cohort analysis |
Link to Journal |
Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa. |
Link to Journal |
National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012-2014 |
Link to Journal |
Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women. |
Link to Journal |
Global Distribution of Human Protoparvoviruses |
Link to Journal |
Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility. |
Link to Journal |